TBPP_Haptoglobin, Hemopexin
TBPP_Haptoglobin, Hemopexin
TBPP_Haptoglobin, Hemopexin
-
- 1 / 9
-
Cartes-fiches
439 AS, single chain protein, 60 kD, 20% carbohydrate, 12 cysteines, 6 disulfide bonds, 0.5-1 mg/ml, homology and structure similar in all vertebrates, acute phase response induced Hpx expression in the liver, increases in response to free heme, other acute phase proteins unchanged, highest heme affinity, binds in equimolar ratio (1 heme), heme bound between 2 domains in a pocket: reversible binding by open/close of the pocket (via linker peptide)
scavenging of cell-free hemoglobin, 1. erythrocyte lysis, 2. tetrameric a2b2 Hb dissociates in ab dimers, 3. ab-dimers bound with high affinity by Hp: prevents oxidative damage, 4. binding to CD163 receptor of a cell. Free Hb = oxidate hotspot, formation of toxic free radicals = inflammation and cytotoxicity, kidney and vascular damage, vasosconstriction (Verstopfung). Hb ab-dimers complexed with Hp are protected from oxidation.
scavenges heme from circulation, physiological removal of old RBC: erythrophagocytosis by macrophages, heme degraded by HO-1, iron recycled, intravascular hemolysis (10%), massive hemolysis: free heme released, binding to albumin and transport to Hpx and then transport to liver. Hpx-heme complex binds to CD91 on hepatocytes, macrophages, neurons = endocytosis. other proteins activated by binding to receptor (for cellular defense)
1. degradation in lysosome, release of heme, 2. heme degradation by Hemoxigenase 1 to CO, Fe2+ and Biliverdin, 7. reduction of Biliverdin to Bilirubin, 5. Bilirubin transport to liver.
source of redox-active iron, produces ROS (damage, inflammation), intercalation into membranes: cell lysis and death, vascular leakage. Prevention by Hpx (no product available on the market)
both proteins are precipitated in Fraction IV-4 and V, co-purification from fraction IC-4, extraction/amonium sulfate (salting out). Hemopexin: filtration --> chr. --> diafiltration/sterile filtration --> capto Q --> BioEX --> final concentration / DF, Haptoglobin: extraction --> chr. --> concentration/pasteurization --> dilution --> concentration / DF
acute or chronic hemolysis in which free Hb causes severe clinical issues. Haptoglobin marketed in Japan (acute hemolysis: burn, trauma, blood transfusion), HELLP syndrome (pregnant women), thermal injury, malaria, AB0 mismatched transfusion, acute infection, sickle cell disease (SCD)
point mutation in Beta-Hb gene, aggregation of Beta-Hb, rigid and sickle-shaped RBC, prone to lysis, symptoms: pro-oxidative damage of free Hb and heme, vaso-occlusive crisis (pain, organ damage), major complications depend on age, heart attack or kidney fail cause to death, high heme concentration inside sickle RBC (lifespan 10-20 days), bone marrow cannot match rate of destruction: more sickle cells = chronic hemolysis, Haptoglobin and Hemopexin depleted in SCD.
Hp/Hpx treatment in SCD mice
Hpx protects the vascular endothelial system from oxidative damage, reduces inflammation (detoxification via liver)and iron accumulation, functional consequence: Hpx therapy normalizes blood pressure and cardiac output, measurements of stasis = vaso-occlusion after repetitive post injections: free Hb-infusion causes stasis, protection only by Hb, Hpx, and Hb+Hpx.